Non–heat inactivated autologous serum increases accuracy of in vitro CFSE lymphocyte proliferation test (LPT) for nickel
Open Access
- 26 March 2020
- journal article
- research article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 50 (6), 722-732
- https://doi.org/10.1111/cea.13603
Abstract
Background Skin patch testing is still seen as the gold standard for the diagnosis of allergic hypersensitivity. For several metals and for patients with a suspected adverse reaction to their medical device implant material, patch testing can be unreliable. The current alternative to metal allergy patch‐testing is the in vitro lymphocyte proliferation test (LPT) using tritiated thymidine. This method is well‐established but requires handling of radioactive material, often uses heat inactivated allogenic human pooled serum and cannot determine T‐cell subsets. Objective To develop a radioactive free LPT by using carboxyfluorescein succinimidyl ester (CFSE) and to evaluate the influence of serum source (heat inactivated human pooled serum (HI HPS) versus autologous serum) on the sensitivity and specificity of the nickel specific LPT. Methods Peripheral blood mononuclear cells derived from nickel allergic patients and healthy controls were collected, labelled with CFSE and cultured in medium containing 10% HI HPS or 10% autologous serum with or without additional T‐cell skewing cytokine cocktails (Th1: IL‐7/IL‐12, Th2: IL‐7/IL‐4, or Th17: IL‐7/IL‐23/IL‐1β) in the absence or presence of NiSO4. The stimulation index (SI) was calculated as the ratio of divided cells, i.e. the percentage of CFSElow/neg CD3+CD4+ T‐lymphocytes upon nickel stimulation compared to the percentage of CFSElow/neg CD3+CD4+ T‐lymphocytes without antigen. These results were compared with the history of Ni allergy, patch‐test results and the MELISA test. Results Autologous serum positively influenced Ni specific proliferation while HI HPS negatively influenced Ni specific proliferation. The test protocol analysing CD4+ cells and autologous serum without skewing cytokines scored the best diagnostic values (sensitivity 95%; specificity 93%; overall accuracy 94%) compared to the parallel test using HI HPS (accuracy 60%). Cytokine supplements did not further improve the test protocol which used autologous serum. The protocol using HI HPS could be further improved by addition of the cytokine skewing cocktails. Conclusions Here we describe an optimized and highly accurate flow cytometric LPT which comprises of CFSE labelled cells cultured in autologous serum (not heat inactivated) and without the presence of T‐cell skewing cytokines.Keywords
Funding Information
- Stichting voor de Technische Wetenschappen (13382)
This publication has 41 references indexed in Scilit:
- Development of a validated blood test for nickel sensitizationJournal of Allergy and Clinical Immunology, 2013
- Current patch test results with the European baseline series and extensions to it from the ‘European Surveillance System on Contact Allergy’ network, 2007–2008Contact Dermatitis, 2012
- Th17/Tc17 infiltration and associated cytokine gene expression in elicitation phase of allergic contact dermatitisBritish Journal of Dermatology, 2009
- Translational Mini-Review Series on Th17 Cells: Development of mouse and human T helper 17 cellsClinical and Experimental Immunology, 2009
- Detection of chromium allergy by cellular in vitro methodsClinical & Experimental Allergy, 2008
- Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4(+) T cellsImmunity, 2008
- Patch testing: pitfalls and performanceCurrent Opinion in Allergy and Clinical Immunology, 2006
- Flow cytometric test for beryllium sensitivityCytometry Part B: Clinical Cytometry, 2004
- Evaluation of immunologic profile in patients with nickel sensitivity due to use of fixed orthodontic appliancesAmerican Journal of Orthodontics and Dentofacial Orthopedics, 2003
- Simultaneous Cytometric Analysis of (Auto)antigen-Reactive T and B Cell ProliferationImmunobiology, 2002